Language selection

Government of Canada / Gouvernement du Canada

Search

ARCHIVED - Canadian National Report on Immunization, 2006

We have archived this page and will not be updating it.

You can use it for research or reference.

We have archived this page and will not be updating it.

You can use it for research or reference.

 

Volume: 32S3 - November 2006

References

  1. Romanow RJ. Building on values: The future of health care in Canada. 2002. URL: <http://www.hc-sc.gc.ca/english/pdf/romanow/pdfs/HCC_Final_Report.pdf>. Date of access: 17 May, 2006.
  2. Bos E, Batson A. Using immunization coverage rates for monitoring health sector performance. Measurement and interpretations issues. World Bank HNP Discussion Papers, 2000.
  3. Laboratory Centre for Disease Control (LCDC), Health Canada, Division of Immunization. Canadian national report on immunization, 1996. CCDR 1997;23S4:1-50.
  4. McWha L, MacArthur A, Badiani T et al. Measuring up: Results from the National Immunization Coverage Survey, 2002. CCDR 2004;30:37-50.
  5. Haimes K, Schouten H, Harris T et al. National standards for immunization coverage assessment: Recommendations from the Canadian Immunization Registry Network. CCDR 2005;31(9):93-6.
  6. Harris T, Belzak L, Schouten-Deehan H et al. National Immunization Coverage Survey of routine childhood vaccines (NICS): Preliminary results. Presented at the 5th Canadian Immunization Conference, 5-8 December, 2004.
  7. Last JM, ed. A dictionary of epidemiology, 4th ed. New York: Oxford University Press, 2001.
  8. Teutsch SM. Considerations in planning a surveillance system. In: Teutsch SM, Churchill RE. Principles and practice of public health surveillance, 2nd ed. New York: Oxford University Press, 2000;17-29.
  9. Doherty JA. Establishing priorities for national communicable disease surveillance. Can J Infect Dis 2000;11:21-4.
  10. Advisory Committee on Epidemiology, Division of Disease Surveillance, Bureau of Infectious Diseases, LCDC, Health Canada. Case definitions for diseases under national surveillance. CCDR 2000;26S3:1-51.
  11. Watkins KW, Deeks SL, Medaglia A et al. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003. CCDR 2006;32(8):97-107.
  12. Xie L, Squires SG, Macey JF et al. Influenza in Canada - 2004-2005 season. CCDR 2006;32(6):45-62.
  13. Sheifele DW, Halperin SA and Members of the CPS/Health Canada, IMPACT. Immunization Monitoring Program, ACTive: A model of active surveillance of vaccine safety. Semin Pediatr Infect Dis 2003;14:213-19.
  14. Canadian Paediatric Society. Canadian Paediatric Surveillance Program, 2004 results. Ottawa: CPS, 1995.
  15. International Circumpolar Surveillance. International Circumpolar Surveillance summary report, year 2002 Data. Anchorage, Alaska: ICS, 2003.
  16. Laboratory Centre for Disease Control (LCDC), Health Canada, Division of Immunization. Canadian national report on immunization, 1998. Paediatr Child Health 1999;4(Suppl C):1-36.
  17. Deeks SL, MacDonald DM, Squires SG et al. Bacterial meningitis in Canada: Hospitalizations (1994-2001). CCDR 2005;31(23):241-7.
  18. Scheifele D, Halperin S, Law B et al. Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001-2003. Can Med Assoc J 2005;172:53-6.
  19. Bloodborne Pathogens Section, Health Care Acquired Infections Division, Health Canada. Acute and chronic hepatitis B in Canada, 2001, Enhanced Hepatitis Strain Surveillance System. Ottawa: Health Canada, 2001.
  20. Bloodborne Pathogens Section, Health Care Acquired Infections Division, Health Canada. Enhanced Sentinel Surveillance of Hepatitis B in Canada, 1999-2004. Implications for immunization policy. Ottawa: Health Canada, 2004.
  21. Wootton S, Scheifele D, Mozel M et al. The epidemiology of influenza in children hospitalized in Canada, 2004-2005, in Immunization Monitoring Program Active (IMPACT) Centres. CCDR 2006;32(7):77-86.
  22. Laboratory Centre for Disease Control (LCDC), Health Canada, Division of Immunization. Canadian national report on immunization, 1997. Paediatr Child Health 1998;3(Suppl B):1-33.
  23. King A, Varughese P, De Serres G et al. Measles elimination in Canada. J Infect Dis 2004;189(Suppl 1):236-42.
  24. Bell A, Fyfe M, Bigham M et al. Outbreak of mumps among young adults - Vancouver, British Columbia. CCDR 1997;23(22):169-72.
  25. Buxton J, Craig C, Daly P et al. An outbreak of mumps among young adults in Vancouver, British Columbia, associated with “rave” parties. Can J Public Health 1999;90:160-3.
  26. Savard C, Godin C. Outbreak of mumps, Montreal, October 1998 to March 1999 - with a particular focus on a school. CCDR 2000;26(8):69-71.
  27. Skowranski DM, De Serres G, MacDonald D et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis 2002;185:1448-53.
  28. Ntezayabo B, De Serres G, Duval B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr Infect Dis J 2003;22:22-7.
  29. Galanis E, King A, Varughese P. The changing age and seasonal profile of pertussis in British Columbia, not Canada. J Infect Dis 2002;186:1537-8.
  30. Mikelova LK, Halperin SA, Scheifele D et al. Predictors of death in infants hospitalized with pertussis: A case-control study of 16 pertussis deaths in Canada. J Pediatr 2003;143:576-81.
  31. Senzilet LD, Halperin SA, Spika JS et al. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001;32:1691-7.
  32. National Advisory Committee on Immunization. Prevention of pertussis in adolescents and adults. CCDR 2003;29(ACS-5):1-9.
  33. Kandola K, Lea A, WhiteWet al. A comparison of pertussis rates in the Northwest Territories: pre and post-cellular pertussis vaccine introduction in children and adolescents. Can J Infect Dis Med Microbiol 2005;16:271-4.
  34. National Advisory Committee on Immunization. Statement on recommended use of pneumococcal conjugate vaccine. CCDR 2002;28(ACS-2):1-32.
  35. Bettinger JA, Scheifele DW, Halperin S et al. Invasive pneumococcal infections in children, 1998-2004. Presented at the 5th Canadian Immunization Conference, Montreal, December 5-8, 2004.
  36. Kellner JD, Church DL, MacDonald J et al. Progress in the prevention of pneumococcal infection. Can Med Assoc J 2005;173:1149-51.
  37. Hahné S, Macey J, Tipples G et al. Rubella outbreak in an unvaccinated religious community in the Netherlands spreads to Canada. Eurosurveillance Wkly 2005;10:19. URL: <http://www.eurosurveillance.org/ew/2005/050519.asp#1>. Date of access: 17 May, 2006.
  38. Van der Veen Y, Hahné S, Ruijs H et al. Rubella outbreak in an unvaccinated religious community in the Netherlands leads to cases of congenital rubella syndrome. EurosurveillanceWkly 2005;10:24. URL: <http://www.eurosurveillance.org/ew/2005/051124.asp>. Date of access: 17 May, 2006.
  39. National Advisory Committee on Immunization. Update on varicella. CCDR 2004;30(ACS-1):1-28.
  40. Law BJ. Chickenpox vaccination, not chickenpox, should be routine for Canadian children. Can Med Assoc J 2001;164:1454-55.
  41. Law B, Scheifele D, MacDonald N et al. The Immunization Monitoring Program ACTive (IMPACT) prospective surveillance of varicella zoster infections among hospitalized Canadian children: 1991-1996. CCDR 2000;26(15):125-32.
  42. Takashi M, Gershon AA. Varicella vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines, 2nd ed. WB Saunders Co, 1994; 387-419.
  43. Koch J, Leet C, McCarthy R et al. Adverse events temporally associated with immunizing agents: 1987 report. CDWR 1989;15:151-8.
  44. Duclos P, McCarthy R, Koch J et al. Adverse events temporally associated with immunizing agents: 1988 report. CDWR 1990;16:157-64.
  45. Duclos P, Koch J, Hardy M et al. Adverse events temporally associated with immunizing agents: 1989 report. CDWR 1991;17:147-51,155-7.
  46. Duclos P, Pless R. Koch J et al. Adverse events temporally associated with immunizing agents - 1990 report. Can Fam Physician 1993;39:1907-13.
  47. Childhood Immunization Division, LCDC. Adverse events temporally associated with immunizing agents - 1991 report. CCDR 1993;19:168-78.
  48. Bentsi-Enchill A, Hardy M, Koch J et al. Adverse events temporally associated with vaccines - 1992 report. CCDR 1995:21(13):117-28.
  49. Collet J-P, MacDonald N, Cashman N et al. Monitoring signals for vaccine safety: The assessment of individual adverse event reports by an expert advisory committee. WHO Bull 2000;78:178-85.
  50. Ahmadipour N, Pless R, Tam T et al. Oculo-respiratory syndrome (ORS) following influenza vaccination: Review of post-marketing surveillance through four influenza seasons in Canada. CCDR 2005;31(21):217-5.
  51. Deeks SL, Clark M, Scheifele DW et al. Serious adverse events associated with Bacille Calmette-Guérin vaccine in Canada. Pediatr Infect Dis J 2005;24:538-41.

 

Page details

Date modified: